Madrigal Pharmaceuticals Inc (MDGL) is a biotechnology company listed on NASDAQ.
Latest reported MDGL revenue for 2026-06-30 was $675.6M. Net income was -$152.3M. MDGL currently screens at market cap $11.56B.
Use this MDGL page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the MDGL quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the MDGL SEC filings page. Lician reads the product cache first so this HTML stays unique to Madrigal Pharmaceuticals Inc even when a live quote feed is slow.
Latest cached year on this hub. Full MDGL income, balance, and cash tables.